Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapracorat for inflammation after cataract surgery
NCT00905450Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Jun 2009
- Primary completion
- Mar 2010
- Countries
- 1
01
Overview
A Phase 2 trial of mapracorat in inflammation, sponsored by Bausch + Lomb. Started Jun 2009; status: completed.
02
Drugs
mapracorat
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT00905450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00905450.